Yeah, give the preso a watch. Paul was extolling the 1.5mg/kg twice weekly as having no difference in effect.
As you say, they must be confident. Hope they're right. Potentially great news from an eventual sales perspective (25% less product for the same price). Makes me a little nervous though, if not for the primary endpoints in the pivotal trial, then levels of efficacy across the extension trials.
Ann: NWR Virtual Healthcare Conference Presentation, page-24
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10756 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 62010 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |